The largest database of trusted experimental protocols

Biotyper version 3

Manufactured by Bruker
Sourced in United States

The BioTyper version 3.1 software is a core identification tool for microbial species. It provides reliable and reproducible identification of microorganisms based on mass spectrometric data.

Automatically generated - may contain errors

5 protocols using biotyper version 3

1

Protein Fingerprinting by MALDI-TOF MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein fingerprinting by means of MALDI-TOF MS using an Ultraflextreme instrument (Bruker Daltonics, Germany) was conducted after a standard extraction protocol (92 (link)). MALDI-TOF mass spectra were obtained using an Ultraflextreme instrument (Bruker Daltonics) operated in linear positive mode using the software FlexControl version 3.4. Signals present in at least seven out of nine independent mass spectra acquired per sample were taken into account. Mass spectra were processed using FlexAnalysis version 3.4 (Bruker Daltonics) and BioTyper version 3.1 software (Bruker Daltonics) supplemented with database version 10.0.0.0 (9,607 entries).
+ Open protocol
+ Expand
2

Protein Fingerprinting by MALDI-TOF MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein fingerprinting by means of MALDI-TOF MS using an Ultraflextreme instrument (Bruker Daltonics, Germany) was conducted after a standard extraction protocol (92 (link)). MALDI-TOF mass spectra were obtained using an Ultraflextreme instrument (Bruker Daltonics) operated in linear positive mode using the software FlexControl version 3.4. Signals present in at least seven out of nine independent mass spectra acquired per sample were taken into account. Mass spectra were processed using FlexAnalysis version 3.4 (Bruker Daltonics) and BioTyper version 3.1 software (Bruker Daltonics) supplemented with database version 10.0.0.0 (9,607 entries).
+ Open protocol
+ Expand
3

Identification of Candida Species by MALDI-TOF MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
All isolates were identified by both Vitek MS system (IVD Knowledgebase version 2.0, bioMérieux, Marcy l’Etoile, France) and Bruker Autoflex Speed TOF/TOF MS system using Biotyper version 3.1 software (Bruker Daltoniks, Billerica, MA, USA) according to the manufacturer’s instructions. For the Vitek MS system, the results were scored in one of three ways, (i) a single identification (confidence value of 60.0 to 99.9%), (ii) a split identification for which a set of possible organisms is displayed, or (iii) NI when no match is found (Zhang et al., 2014 (link)). C. nivariensis and C. bracarensis reference spectra are not included in the Vitek MS v2.0 database. With the Bruker system, identification was provided according to manufacturer-determined criteria: a spectral score of <1.700 was considered not to provide reliable identification. A score of 1.700 but <2.000 indicated identification at the genus level, and a score of ≥2.000, identification at the species level (Deak et al., 2015 (link)). The current Bruker Daltonik v3.1 database contains 5,989 MSPs, which include reference spectra of C. nivariensis and C. bracarensis.
+ Open protocol
+ Expand
4

Haemophilus influenzae Isolation and Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Routine sputum culture was performed using homogenized sputum according to the Health Protection Agency (HPA) standard operating procedures. All cultured organisms were identified by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry on a Microflex LT using Biotyper, version 3.1 (Bruker Daltonics, Ballerica, MA, USA). In addition, prospective Haemophilus species were also identified using X (hemin), V (NAD) and XV disks (hemin and NAD) (BD BBL Taxo differentiation discs for Haemophilus spp., Wokingham, UK) on nutrient agar (Oxoid Ltd, Basingstoke, UK). H. influenzae strains isolated from 4 clinical samples (PID 278, 133, 29 and 288) were cultured overnight (37°C with 5% CO2, shaking at 180 rpm) in 10 mL culture broth (BHI with 10 μg/mL NAD [NAD] and hemin [Sigma-Aldrich, Dorset, UK]). Once optical density at 600 nm reached 0.5 (exponential phase) bacteria were pelleted and resuspended in BHI containing 10% glycerol and stored at −80°C until use. Clinical laboratory results from the John Radcliffe Hospital Microbiology Laboratory, Oxford, UK have been provided for three samples.
+ Open protocol
+ Expand
5

Retrospective Study of C. difficile Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
A retrospective study was performed at the Cambridge University Hospitals NHS Foundation Trust between October 2012 and April 2013. Stool samples were processed at the on-site Public Health England Clinical Microbiology and Public Health Laboratory. Samples were tested using a commercial assay (C. DIFF QUIK CHEK COMPLETE; Techlab), which detects glutamate dehydrogenase (GDH) antigen and toxins A and B of C. difficile. Positive samples were cultured anaerobically for 48 h onto Brazier’s cycloserine-cefoxitin-egg yolk (CCEY) agar (BioConnections) using alcohol shock (https://www.gov.uk/government/publications/smi-b-10-processing-of-faeces-for-clostridium-difficile) and colonies with typical appearance were identified by MALDI-TOF MS (Biotyper version 3.1; Bruker Daltonics). Stool samples from which C. difficile was isolated were stored at −80 °C prior to repeated recovery of C. difficile, DNA extraction and sequencing. Clinical data were recorded on patient age, gender, date of hospital admission, discharge and ward movement, and previous admission to hospital in the preceding 6 months. Recurrent C. difficile infection was defined as the onset of diarrhoea 4 weeks or more after the end of the prior episode.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!